You are about to leave the Clinical Value website now.


APPLE 2021 – Biomarker In HCC Surveillance And Treatment: The New Evidence On The Horizon


Prof. Chiun Hsu

Professor, National Taiwan University
Director, National Taiwan University Cancer Center

Prof. Henry Chan

Deputy Chief Hospital Manager at Union Hospital in Hong Kong, and Honorary Clinical Professor of the Faculty of Medicine at The Chinese University of Hong Kong

Prof. Hui Chuan Sun

Deputy Head, Department of Liver Surgery and Transplantation, Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China

PIVKA-II and GAAD in HCC surveillance

The value of biomarkers in immunotherapy of HCC



This content is targeted at healthcare professionals and could contain information otherwise not accessible, approved or valid in your country. Please be aware that we do not take any responsibility for you accessing information which may not comply with any legal process, regulation, registration or usage in the country of your origin.This content is for general information purposes only. We disclaim all liability and are not responsible for any third party content on our website or which our website links to.

Be the first to receive updates, event opportunities, and thought leadership insights.